IOVANCE BIOTHERAPEUTICS, INC.: capex
| Value | {"amount": 20316, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2011-01-01 – 2011-09-30 |
| Status | current |
| Entity | IOVANCE BIOTHERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:00:04.907095+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d684c471-f82a-48e3-bfc9-ee904071ba12
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001513160-13-000022Retrieved: 2026-08-19T14:00:04.907095+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001425205/capex/2011-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d684c471-f82a-48e3-bfc9-ee904071ba12
History
- supersedes {"amount": -20316, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001144204-11-066214)